ERBB2 and cancer: Several oncogenic agents and signals including epidermal growth factor (EGF), androgen and ErbB‐2 potently activate matriptase in cancer cells and tissues.6, 7, 8, 9 Therefore, matriptase is a potent oncogenic protein, making it a potential drug target for cancer therapy.